• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多种致癌途径特征在人类前列腺肿瘤中显示出协同表达模式。

Multiple oncogenic pathway signatures show coordinate expression patterns in human prostate tumors.

作者信息

Creighton Chad J

机构信息

Division of Biostatistics, Department of Medicine, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, United States of America.

出版信息

PLoS One. 2008 Mar 19;3(3):e1816. doi: 10.1371/journal.pone.0001816.

DOI:10.1371/journal.pone.0001816
PMID:18350153
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2263127/
Abstract

BACKGROUND

Gene transcription patterns associated with activation of oncogenes Myc, c-Src, beta-catenin, E2F3, H-Ras, HER2, EGFR, MEK, Raf, MAPK, Akt, and cyclin D1, as well as of the cell cycle and of androgen signaling have been generated in previous studies using experimental models. It was not clear whether genes in these "oncogenic signatures" would show coordinate expression patterns in human prostate tumors, particularly as most of the signatures were derived from cell types other than prostate.

PRINCIPAL FINDINGS

The above oncogenic pathway signatures were examined in four different gene expression profile datasets of human prostate tumors (representing approximately 250 patients in all), using both Q1-Q2 and one-sided Fisher's exact enrichment analysis methods. A significant fraction (approximately 5%) of genes up-regulated experimentally by Myc, c-Src, HER2, Akt, or androgen were co-expressed in human tumors with the oncogene or biomarker corresponding to the pathway signature. Genes down-regulated experimentally, however, did not show anticipated patterns of anti-enrichment in the human tumors.

CONCLUSIONS

Significant subsets of the genes in these experimentally-derived oncogenic signatures are relevant to the study of human prostate cancer. Both molecular biologists and clinical researchers could focus attention on the relatively small number of genes identified here as having coordinate patterns that arise from both the experimental system and the human disease system.

摘要

背景

在先前的研究中,已利用实验模型生成了与癌基因Myc、c-Src、β-连环蛋白、E2F3、H-Ras、HER2、EGFR、MEK、Raf、MAPK、Akt和细胞周期蛋白D1的激活相关的基因转录模式,以及细胞周期和雄激素信号传导的基因转录模式。尚不清楚这些“致癌特征”中的基因在人类前列腺肿瘤中是否会表现出协同表达模式,尤其是因为大多数特征源自前列腺以外的细胞类型。

主要发现

使用Q1-Q2和单侧Fisher精确富集分析方法,在人类前列腺肿瘤的四个不同基因表达谱数据集中(总共代表约250名患者)检查了上述致癌途径特征。在实验中由Myc、c-Src、HER2、Akt或雄激素上调的基因中有很大一部分(约5%)在人类肿瘤中与对应途径特征的癌基因或生物标志物共表达。然而,在实验中下调的基因在人类肿瘤中并未显示出预期的反富集模式。

结论

这些实验衍生的致癌特征中的基因的重要子集与人类前列腺癌的研究相关。分子生物学家和临床研究人员都可以关注这里确定的相对少数具有协同模式的基因,这些模式源自实验系统和人类疾病系统。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e3d/2263127/f89588c3be7a/pone.0001816.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e3d/2263127/d5ede1f37edc/pone.0001816.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e3d/2263127/f89588c3be7a/pone.0001816.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e3d/2263127/d5ede1f37edc/pone.0001816.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e3d/2263127/f89588c3be7a/pone.0001816.g002.jpg

相似文献

1
Multiple oncogenic pathway signatures show coordinate expression patterns in human prostate tumors.多种致癌途径特征在人类前列腺肿瘤中显示出协同表达模式。
PLoS One. 2008 Mar 19;3(3):e1816. doi: 10.1371/journal.pone.0001816.
2
Alterations in mRNA levels for growth-related genes after transplantation into castrated hosts in oncogene-induced clonal mouse prostate carcinoma.癌基因诱导的克隆性小鼠前列腺癌移植到去势宿主后,生长相关基因的mRNA水平变化。
Mol Carcinog. 1992;5(1):52-61. doi: 10.1002/mc.2940050110.
3
Complementation of defective colony-stimulating factor 1 receptor signaling and mitogenesis by Raf and v-Src.Raf和v-Src对缺陷型集落刺激因子1受体信号传导及有丝分裂的互补作用。
Mol Cell Biol. 1999 Feb;19(2):1101-15. doi: 10.1128/MCB.19.2.1101.
4
Novel oncogene-induced metastatic prostate cancer cell lines define human prostate cancer progression signatures.新型癌基因诱导转移性前列腺癌细胞系定义了人类前列腺癌进展特征。
Cancer Res. 2013 Jan 15;73(2):978-89. doi: 10.1158/0008-5472.CAN-12-2133. Epub 2012 Nov 30.
5
Increased Akt signaling resulting from the loss of androgen responsiveness in prostate cancer.前列腺癌中由于雄激素反应丧失导致 Akt 信号转导增加。
Curr Med Chem. 2013;20(1):144-57.
6
Src family kinase oncogenic potential and pathways in prostate cancer as revealed by AZD0530.AZD0530揭示的Src家族激酶在前列腺癌中的致癌潜力及通路
Oncogene. 2008 Oct 23;27(49):6365-75. doi: 10.1038/onc.2008.250. Epub 2008 Aug 4.
7
Association between bivariate expression of key oncogenes and metabolic phenotypes of patients with prostate cancer.前列腺癌患者关键致癌基因的双变量表达与代谢表型的相关性。
Comput Biol Med. 2018 Dec 1;103:55-63. doi: 10.1016/j.compbiomed.2018.09.017. Epub 2018 Oct 4.
8
Single cell genomics reveals activation signatures of endogenous SCAR's networks in aneuploid human embryos and clinically intractable malignant tumors.单细胞基因组学揭示了非整倍体人类胚胎和临床上难以治疗的恶性肿瘤中内源性 SCAR 网络的激活特征。
Cancer Lett. 2016 Oct 10;381(1):176-93. doi: 10.1016/j.canlet.2016.08.001. Epub 2016 Aug 3.
9
MiR-182 promotes prostate cancer progression through activating Wnt/β-catenin signal pathway.miR-182 通过激活 Wnt/β-catenin 信号通路促进前列腺癌进展。
Biomed Pharmacother. 2018 Mar;99:334-339. doi: 10.1016/j.biopha.2018.01.082.
10
Tumorigenic conversion of primary human esophageal epithelial cells using oncogene combinations in the absence of exogenous Ras.在无外源性Ras的情况下使用癌基因组合对原代人食管上皮细胞进行致瘤性转化。
Cancer Res. 2006 Nov 1;66(21):10415-24. doi: 10.1158/0008-5472.CAN-06-2104.

引用本文的文献

1
Biguanides antithetically regulate tumor properties by the dose-dependent mitochondrial reprogramming-driven c-Src pathway.双胍类药物通过剂量依赖性线粒体重编程驱动的c-Src途径反向调节肿瘤特性。
Cell Rep Med. 2025 Feb 18;6(2):101941. doi: 10.1016/j.xcrm.2025.101941. Epub 2025 Feb 10.
2
Proteogenomic characterization of 2002 human cancers reveals pan-cancer molecular subtypes and associated pathways.2002 例人类癌症的蛋白质基因组学特征分析揭示了泛癌分子亚型及相关途径。
Nat Commun. 2022 May 13;13(1):2669. doi: 10.1038/s41467-022-30342-3.
3
The Sca-1 and Sca-1 mouse prostatic luminal cell lineages are independently sustained.

本文引用的文献

1
Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis.在预后不良的侵袭性人类乳腺癌、前列腺癌和肺癌中鉴定出一种整合的SV40 T/t抗原癌症特征。
Cancer Res. 2007 Sep 1;67(17):8065-80. doi: 10.1158/0008-5472.CAN-07-1515.
2
Genes regulated by estrogen in breast tumor cells in vitro are similarly regulated in vivo in tumor xenografts and human breast tumors.雌激素在体外对乳腺肿瘤细胞中基因的调控,与在体内肿瘤异种移植和人类乳腺肿瘤中的调控方式相似。
Genome Biol. 2006;7(4):R28. doi: 10.1186/gb-2006-7-4-r28. Epub 2006 Apr 7.
3
Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.
Sca-1 和 Sca-1 小鼠前列腺腔细胞谱系是独立维持的。
Stem Cells. 2020 Nov;38(11):1479-1491. doi: 10.1002/stem.3253. Epub 2020 Aug 8.
4
Pan-cancer molecular subtypes revealed by mass-spectrometry-based proteomic characterization of more than 500 human cancers.基于超过 500 种人类癌症的基于质谱的蛋白质组学特征分析揭示的泛癌分子亚型。
Nat Commun. 2019 Dec 12;10(1):5679. doi: 10.1038/s41467-019-13528-0.
5
Metabolic Dysregulation Controls Endocrine Therapy-Resistant Cancer Recurrence and Metastasis.代谢失调控制内分泌治疗耐药性癌症的复发和转移。
Endocrinology. 2019 Aug 1;160(8):1811-1820. doi: 10.1210/en.2019-00097.
6
Pan-Cancer Molecular Classes Transcending Tumor Lineage Across 32 Cancer Types, Multiple Data Platforms, and over 10,000 Cases.泛癌种分子亚型跨越 32 种癌症类型、多个数据平台和超过 10000 例病例。
Clin Cancer Res. 2018 May 1;24(9):2182-2193. doi: 10.1158/1078-0432.CCR-17-3378. Epub 2018 Feb 9.
7
Pan-urologic cancer genomic subtypes that transcend tissue of origin.超越起源组织的泛泌尿生殖系统癌症基因组亚型。
Nat Commun. 2017 Aug 4;8(1):199. doi: 10.1038/s41467-017-00289-x.
8
Thy-1 Cancer-associated Fibroblasts Adversely Impact Lung Cancer Prognosis.肿瘤相关成纤维细胞 Thy-1 对肺癌预后有不良影响。
Sci Rep. 2017 Jul 25;7(1):6478. doi: 10.1038/s41598-017-06922-5.
9
Simultaneous inhibition of aryl hydrocarbon receptor (AhR) and Src abolishes androgen receptor signaling.同时抑制芳烃受体(AhR)和Src可消除雄激素受体信号传导。
PLoS One. 2017 Jul 3;12(7):e0179844. doi: 10.1371/journal.pone.0179844. eCollection 2017.
10
A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations.PI3K/AKT/mTOR信号通路改变的泛癌蛋白质基因组图谱
Cancer Cell. 2017 Jun 12;31(6):820-832.e3. doi: 10.1016/j.ccell.2017.04.013. Epub 2017 May 18.
体外雌激素受体α阳性乳腺癌细胞中丝裂原活化蛋白激酶的激活可诱导雌激素受体α阴性人类乳腺肿瘤的体内分子表型。
Cancer Res. 2006 Apr 1;66(7):3903-11. doi: 10.1158/0008-5472.CAN-05-4363.
4
Oncogenic pathway signatures in human cancers as a guide to targeted therapies.人类癌症中的致癌途径特征作为靶向治疗的指导
Nature. 2006 Jan 19;439(7074):353-7. doi: 10.1038/nature04296. Epub 2005 Nov 6.
5
Discovering statistically significant pathways in expression profiling studies.在基因表达谱研究中发现具有统计学意义的通路。
Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13544-9. doi: 10.1073/pnas.0506577102. Epub 2005 Sep 8.
6
Molecular pathology of prostate cancer.前列腺癌的分子病理学
J Clin Pathol. 2005 Jul;58(7):673-84. doi: 10.1136/jcp.2002.003954.
7
An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis.通过跨物种基因表达分析鉴定出的致癌性KRAS2表达特征。
Nat Genet. 2005 Jan;37(1):48-55. doi: 10.1038/ng1490. Epub 2004 Dec 19.
8
Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy.前列腺癌中的基因表达改变可预测肿瘤侵袭性及恶性肿瘤的前期发展。
J Clin Oncol. 2004 Jul 15;22(14):2790-9. doi: 10.1200/JCO.2004.05.158.
9
Java Treeview--extensible visualization of microarray data.Java树状视图——微阵列数据的可扩展可视化工具。
Bioinformatics. 2004 Nov 22;20(17):3246-8. doi: 10.1093/bioinformatics/bth349. Epub 2004 Jun 4.
10
mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways.mTOR抑制通过调节凋亡和HIF-1依赖途径逆转Akt依赖的前列腺上皮内瘤变。
Nat Med. 2004 Jun;10(6):594-601. doi: 10.1038/nm1052. Epub 2004 May 23.